Common Contracts

5 similar Registration Rights Agreement contracts by INVO Bioscience, Inc., Octus Inc, Revolutions Medical CORP, others

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 17th, 2012 • Sunpeaks Ventures, Inc. • Metal mining • Nevada

THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is dated as of the 30th day of November, 2012, and made effective as of the “Effective Date” (as defined in the CEF Agreement), by and between SUNPEAKS VENTURES, INC., a Nevada corporation (the “Company”) and TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the “Investor”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • August 21st, 2012 • Tree Top Industries, Inc. • Services-computer programming, data processing, etc. • New York

THIS REGISTRATION RIGHTS AGREEMENT (this “ Agreement ”), dated as of the 15th day of August 2012 (the “Agreement”) between AGS Capital Group, LLC (the “Investor”), and Tree Top Industries, Inc. (the “Company”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • February 14th, 2012 • Revolutions Medical CORP • Surgical & medical instruments & apparatus • Florida

THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of the 29th day of December, 2011 by and between REVOLUTIONS MEDICAL CORPORATION, a Nevada corporation (the “Company”) and TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman Islands limited partnership (the “Investor”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 11th, 2009 • Octus Inc • Blank checks • New York

REGISTRATION RIGHTS AGREEMENT (this “ Agreement ”), dated as of December 6, 2009, by and between Octus Inc., a Nevada corporation (the “ Company ”), and AGS Capital Group, LLC, (the “ Investor ”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • November 3rd, 2009 • INVO Bioscience, Inc. • Surgical & medical instruments & apparatus • New York

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 28, 2009, by and between INVO Bioscience, Inc., a Nevada corporation (the “Company”), and AGS Capital Group, LLC, (the Investor”).